Amneal Pharmaceuticals Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Amneal Pharmaceuticals Inc with three other
companies in this sector in the United States:
Biomarin Pharmaceutical Inc
sales of $1.49 billion
of which 32%
Hikma Pharmaceuticals PLC
of which 40%
was Injectable Pharmaceuticals), and
United Therapeutics Corporation
of which 37%
Amneal Pharmaceuticals Inc reported sales of $1.66 billion
December of 2018.
increase of 114.4%
versus 2017, when the company's sales were $775.79 million.